ATHAGORAS Group acquires CSO Pharma Consulting to enhance its consulting services in the pharmaceutical industry, combining expertise to drive innovation and growth.
Target Company Overview
CSO Pharma Consulting GmbH, based in Munich, Germany, specializes in providing consulting services within the pharmaceutical and healthcare sectors. The company excels in the areas of pharmacovigilance, medical affairs, quality management, and Good Distribution Practice (GDP) consulting. This acquisition by ATHAGORAS Group positions CSO to enhance its service offerings and leverage ATHAGORAS’ industry presence to drive further innovation and growth.
As a trusted partner for pharmaceutical companies and healthcare providers, CSO Pharma Consulting offers an audited pharmacovigilance system and tailored consulting solutions. Their emphasis on individual consulting paired with robust operational support enables them to meet diverse client needs effectively, thereby maintaining high levels of customer satisfaction.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Germany
The pharmaceutical and healthcare consulting industry in Germany is experiencing rapid growth, fueled by increasing regulatory demands and heightened focus on patient safety.
Similar Deals
Wellhub → Urban Sports Club
2025
Teleflex Incorporated → Vascular Intervention division of BIOTRONIK
2025
Bristol Myers Squibb → Evotec SE
2025
Viessmann Generations Group → schülke
2024
ATHAGORAS Group
invested in
CSO Pharma Consulting
in 2024
in a Strategic Partnership deal